Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues

Schizophrenia Bulletin
D M Ziedonis, T P George

Abstract

Nicotine use is a major public health problem that increases medical morbidity and mortality. Nicotine's action and the pathobiology of schizophrenic disorders have common neurobiological substrates. Tobacco smoking alters medication blood levels and effectiveness, modifies psychiatric symptoms, and is a clue for other substance abuse. This article presents an evaluation of a smoking cessation program for 24 smokers with schizophrenia. Fifty percent completed the program, 40 percent decreased use by 50 percent, and 13 percent remained abstinent (carbon monoxide verified) for 6 months. Nicotine replacement, motivational enhancement therapy, and relapse prevention behavioral therapy were important components of treatment. Pharmacotherapy strategies of a higher-dose nicotine patch, combining nicotine gum and a patch, and augmentation medication to nicotine replacement should be evaluated in future studies in this population.

Citations

Jul 24, 2012·Current Psychiatry Reports·Kristen M MackowickTony P George
May 5, 2005·Drug and Alcohol Dependence·Jennifer W TideyRobert M Swift
Feb 18, 2004·International Journal of Nursing Studies·Kuei-Ru ChouRu-Band Lu
Apr 23, 2013·Psychiatry Research·Wakako Umene-NakanoJun Nakamura
Jun 25, 2002·Biological Psychiatry·Tony P GeorgeThomas R Kosten
Dec 7, 2002·Psychiatry Research·Stephanie A McDermid Vaz, R Walter Heinrichs
Feb 1, 2002·Social Science & Medicine·Sharon J LawnJames G Barber
Jun 1, 1999·Journal of Substance Abuse Treatment·C Rosen-Chase, V Dyson
Feb 27, 2004·Schizophrenia Research·Howard C MargoleseKathryn Gill
Jul 6, 2000·European Psychiatry : the Journal of the Association of European Psychiatrists·P Batel
Jul 16, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Huiping ZhangJoel Gelernter
Feb 29, 2008·Journal of Psychoactive Drugs·Sandra M GallagherWendy Layne
Aug 9, 2005·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Jennifer W TideyRobert M Swift
Jun 28, 2008·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Jennifer W TideyAmy B Adolfo
Nov 10, 2000·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·G W Dalack, J H Meador-Woodruff
Jan 5, 2002·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·S M Hall
Sep 27, 2005·Journal of Psychiatric Practice·Douglas M ZiedonisRoger D Weiss
Sep 9, 2005·American Journal of Therapeutics·Jennifer L Derenne, Ross J Baldessarini
Mar 31, 2009·Annual Review of Clinical Psychology·Sharon M Hall, Judith J Prochaska
Nov 28, 2012·Therapeutic Advances in Endocrinology and Metabolism·Evangelos Papanastasiou
Nov 26, 2008·The Journal of Clinical Psychiatry·Melissa A CulhaneA Eden Evins
Aug 15, 2013·European Archives of Psychiatry and Clinical Neuroscience·Dieter SchoepfReinhard Heun
Dec 1, 2014·Current Addiction Reports·Sarah C AkermanAlan I Green
Aug 23, 2006·Issues in Mental Health Nursing·Marsha Snyder
Jul 22, 2004·Current Medical Research and Opinion·Nadège RipollMichel Bourin
Feb 1, 2011·Behavioural Brain Research·Hiroyuki MizoguchiKiyofumi Yamada
Nov 30, 2010·Schizophrenia Research·Monica C Mann-WrobelM Patricia Ball
Apr 7, 2010·Journal of Substance Abuse Treatment·Jill M WilliamsDouglas M Ziedonis
Jul 24, 2010·Archives of Psychiatric Nursing·Mary GriffithsJacky Chan
Mar 1, 2009·Revista de psiquiatrí́a y salud mental·Mario Maj
Dec 30, 2015·American Journal of Preventive Medicine·Erin S RogersScott E Sherman
Dec 18, 2007·European Psychiatry : the Journal of the Association of European Psychiatrists·Arnstein MykletunRobert Stewart
Aug 28, 2007·The Psychiatric Clinics of North America·Deanna L KellyRobert R Conley
Jul 31, 2007·Schizophrenia Research·Mounir H FawziMaggie M Fawzi
Feb 10, 2007·Psychiatry Research·Amanda BakerKristen Moeller-Saxone

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.